Robert Iannone
Tracked across 1 events · 6 articles · First seen Jul 13, 2026 · Last active Jul 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Robert Iannone was appointed to the board, contributing drug development and regulatory expertise from Jazz Pharmaceuticals, AstraZeneca, Gilead Sciences — Immunomedics, and Merck.
Jul 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Robert Iannone live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard